
Quick Heal (QUICKHEAL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
651.4M
Gross Profit
148.0M
22.72%
Operating Income
-121.1M
-18.59%
Net Income
-32.5M
-4.99%
Balance Sheet Metrics
Total Assets
5.3B
Total Liabilities
835.6M
Shareholders Equity
4.4B
Debt to Equity
0.19
Cash Flow Metrics
Revenue & Profitability Trend
Quick Heal Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 2.8B | 2.9B | 2.8B | 3.4B | 3.3B |
Cost of Goods Sold | 1.9B | 1.8B | 1.6B | 1.5B | 1.3B |
Gross Profit | 868.5M | 1.2B | 1.1B | 1.9B | 2.0B |
Gross Margin % | 31.1% | 40.0% | 40.9% | 56.2% | 61.3% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 398.3M | 619.2M | 438.2M | 334.6M |
Other Operating Expenses | 934.4M | 453.1M | 381.7M | 291.4M | 187.0M |
Total Operating Expenses | 934.4M | 851.4M | 1.0B | 729.6M | 521.6M |
Operating Income | -195.5M | 54.2M | -134.0M | 897.0M | 1.3B |
Operating Margin % | -7.0% | 1.9% | -4.8% | 26.2% | 37.7% |
Non-Operating Items | |||||
Interest Income | - | 12.9M | 17.8M | 29.0M | 71.3M |
Interest Expense | 2.2M | 1.3M | 0 | - | - |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 10.0M | 262.1M | 80.2M | 1.1B | 1.5B |
Income Tax | -40.4M | 19.7M | 16.2M | 254.9M | 391.6M |
Effective Tax Rate % | -404.0% | 7.5% | 20.2% | 23.5% | 26.8% |
Net Income | 50.4M | 242.4M | 64.0M | 831.9M | 1.1B |
Net Margin % | 1.8% | 8.3% | 2.3% | 24.3% | 32.1% |
Key Metrics | |||||
EBITDA | 141.8M | 249.5M | 99.8M | 954.3M | 1.4B |
EPS (Basic) | ₹0.94 | ₹4.56 | ₹1.14 | ₹14.01 | ₹16.66 |
EPS (Diluted) | ₹0.94 | ₹4.48 | ₹1.14 | ₹13.94 | ₹16.65 |
Basic Shares Outstanding | 53617021 | 53195385 | 55928126 | 59381642 | 64204491 |
Diluted Shares Outstanding | 53617021 | 53195385 | 55928126 | 59381642 | 64204491 |
Income Statement Trend
Quick Heal Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 208.4M | 375.1M | 115.8M | 78.3M | 164.3M |
Short-term Investments | 1.7B | 1.8B | 1.8B | 3.5B | 4.5B |
Accounts Receivable | 1.7B | 1.3B | 1.2B | 1.7B | 1.5B |
Inventory | 22.2M | 28.0M | 45.0M | 47.9M | 33.4M |
Other Current Assets | 79.2M | 13.6M | 6.0M | 400.0K | 200.0K |
Total Current Assets | 3.7B | 3.6B | 3.2B | 5.3B | 6.3B |
Non-Current Assets | |||||
Property, Plant & Equipment | 834.8M | 109.5M | 94.9M | 94.9M | 100.5M |
Goodwill | 7.2M | 14.9M | 27.7M | 57.5M | 52.8M |
Intangible Assets | 7.2M | 14.9M | 27.7M | 57.5M | 52.8M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 13.5M | 100.0K | 1.5M | -100.0K | 10.0K |
Total Non-Current Assets | 1.5B | 1.5B | 1.7B | 1.8B | 2.0B |
Total Assets | 5.3B | 5.1B | 4.9B | 7.2B | 8.3B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 349.3M | 398.8M | 486.1M | 497.0M | 499.8M |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 238.8M | 9.3M | 21.4M | 27.1M | 32.0M |
Total Current Liabilities | 787.1M | 733.0M | 719.4M | 862.0M | 740.2M |
Non-Current Liabilities | |||||
Long-term Debt | 900.0K | - | - | - | - |
Deferred Tax Liabilities | - | 0 | 5.3M | 6.4M | 8.2M |
Other Non-Current Liabilities | 40.2M | 23.3M | 5.2M | 5.2M | - |
Total Non-Current Liabilities | 48.5M | 23.3M | 16.5M | 20.5M | 11.9M |
Total Liabilities | 835.6M | 756.3M | 735.9M | 882.5M | 752.1M |
Equity | |||||
Common Stock | 540.0M | 535.1M | 530.7M | 580.1M | 642.1M |
Retained Earnings | - | 3.2B | 3.0B | 5.0B | 5.8B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 4.4B | 4.4B | 4.2B | 6.3B | 7.5B |
Key Metrics | |||||
Total Debt | 900.0K | 0 | 0 | 0 | 0 |
Working Capital | 2.9B | 2.9B | 2.5B | 4.5B | 5.6B |
Balance Sheet Composition
Quick Heal Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 10.0M | 262.1M | 80.2M | 1.1B | 1.5B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 99.5M | 51.0M | 28.5M | 46.9M | 6.2M |
Working Capital Changes | -275.2M | -195.3M | 282.3M | -158.3M | -286.2M |
Operating Cash Flow | -173.4M | 103.6M | 354.4M | 946.4M | 1.1B |
Investing Activities | |||||
Capital Expenditures | -140.8M | -64.8M | 11.2M | -13.6M | -88.2M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -2.7B | -2.8B | -4.0B | -4.1B | -6.2B |
Investment Sales | 2.9B | 2.9B | 5.8B | 5.3B | 5.3B |
Investing Cash Flow | 155.1M | 50.6M | 1.8B | 1.2B | -1.0B |
Financing Activities | |||||
Share Repurchases | - | 0 | -1.5B | -1.6B | 0 |
Dividends Paid | -161.3M | -132.9M | -260.9M | -231.5M | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | -102.2M | 16.0M | -2.1B | -2.1B | 1.0M |
Free Cash Flow | -367.2M | 106.3M | 267.3M | 741.3M | 897.6M |
Net Change in Cash | -120.5M | 170.2M | 66.5M | 36.2M | 109.5M |
Cash Flow Trend
Quick Heal Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
300.89
Price to Book
3.45
Price to Sales
5.72
PEG Ratio
-1.29
Profitability Ratios
Profit Margin
-1.69%
Operating Margin
-22.17%
Return on Equity
1.14%
Return on Assets
0.96%
Financial Health
Current Ratio
4.72
Debt to Equity
0.02
Beta
-0.33
Per Share Data
EPS (TTM)
₹-0.82
Book Value per Share
₹81.50
Revenue per Share
₹49.10
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
quickheal | 15.2B | 300.89 | 3.45 | 1.14% | -1.69% | 0.02 |
Tata Elxsi | 353.9B | 47.39 | 12.37 | 27.45% | 20.00% | 6.72 |
KFin Technologies | 194.4B | 57.13 | 13.78 | 23.63% | 29.29% | 3.31 |
Network People | 44.6B | 121.98 | 43.02 | 43.26% | 24.81% | 9.18 |
63 Moons | 42.9B | 42.53 | 1.25 | -0.97% | -32.75% | 0.08 |
Technvision Ventures | 26.4B | 10,361.11 | 340.38 | 0.70% | -0.86% | 25.93 |
Financial data is updated regularly. All figures are in the company's reporting currency.